Black Rock Inc. Aytu Biopharma, Inc Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.15 - $4.0 $83 - $2,220	-555 Reduced 0.12%	481,195 $91,000
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $163 - $3,271	-861 Reduced 0.18%	481,750 $89,000
Q2 2022 Aug 12, 2022	SELL	$0.46 - $1.08 $29,116 - $68,359	-63,296 Reduced 11.59%	482,611 $333,000
Q1 2022 May 12, 2022	SELL	$1.08 - $1.55 $3,042 - $4,366	-2,817 Reduced 0.51%	545,907 $589,000
Q4 2021 Feb 10, 2022	BUY	$1.35 - $2.95 $67,192 - $146,827	49,772 Added 9.98%	548,724 $741,000
Q3 2021 Nov 09, 2021	BUY	$2.78 - $5.12 $43,101 - $79,380	15,504 Added 3.21%	498,952 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $2.29 Million - $3.65 Million	483,448 New	483,448 $2.42 Million

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.